HROW
Harrow Health Inc
33.10$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -425.0% | -114.7% | -56.2% | -32.9% | 1.7% | 1.9% | -2.3% | 7.0% | 1.9% | 2.9% | -11.1% | 16.1% | |
| 5.1% | 6.3% | 7.1% | 6.6% | 4.5% | 5.2% | 5.6% | 3.3% | 4.1% | 9.5% | 7.3% | 7.2% | |
| 157.5% | 35.4% | 18.4% | 11.0% | 6.4% | 4.0% | 5.7% | 7.9% | 9.0% | 12.1% | 8.8% | 4.6% | |
| 157.5% | 35.4% | 10.6% | -1.0% | -47.9% | -0.7% | 7.2% | 8.9% | 12.4% | – | – | – | |
| 21.8% | 3.3% | -3.4% | 2.6% | 8.3% | -3.4% | -12.8% | -0.3% | -6.3% | -5.5% | -22.4% | 0.1% | |
| 10.5% | 12.1% | 35.8% | 4.0% | 5.3% | 3.6% | 2.0% | 39.3% | 8.8% | 117.2% | 19.4% | 0.4% | |
| -54.9% | -52.8% | -36.6% | -3.6% | -5.3% | -3.6% | -2.0% | -25.8% | -2.0% | -117.2% | -16.6% | -2.0% | |
| 0.6% | 84.9% | 21.6% | – | 0.3% | 0.2% | 0.1% | 0.2% | 1.0% | – | – | – | |
| -0.8% | 10.5% | -0.4% | 15.8% | 11.8% | 1.5% | -0.1% | -15.2% | -1.0% | -10.0% | – | – | |
| -0.6% | 93.7% | 11.6% | 2.6% | -1.8% | -1.5% | 3.0% | 76.0% | 35.8% | 57.3% | 14.9% | 4.9% | |
| 36.0% | 110.6% | 123.7% | 18.4% | 10.0% | -2.0% | 2.9% | 71.0% | 61.1% | 97.2% | 14.3% | -4.7% | |
| -443.8% | -56.9% | 30.9% | -18.1% | 6.3% | -3.7% | -1.3% | 52.2% | 61.1% | -17.0% | -13.4% | 9.4% | |
| -435.5% | -126.8% | -92.0% | -36.9% | -3.7% | -1.7% | -4.3% | -32.3% | -6.8% | -114.2% | -30.5% | 15.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.